EKF Diagnostics (LON:EKF) Shares Cross Above Two Hundred Day Moving Average – Should You Sell?

Shares of EKF Diagnostics Holdings plc (LON:EKF) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 23.79 ($0.32) and traded as high as GBX 25.90 ($0.35). EKF Diagnostics shares last traded at GBX 25 ($0.34), with a volume of 261 shares.

EKF Diagnostics Stock Down 1.2%

The firm has a 50 day moving average of GBX 22.44 and a 200-day moving average of GBX 23.78. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.60 and a quick ratio of 1.77. The stock has a market capitalization of £111.12 million, a P/E ratio of 23.27 and a beta of 0.57.

EKF Diagnostics (LON:EKF) last released its quarterly earnings data on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) earnings per share (EPS) for the quarter. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%. On average, equities research analysts expect that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Gavin T. Jones bought 50,000 shares of the business’s stock in a transaction that occurred on Tuesday, March 25th. The stock was acquired at an average price of GBX 22 ($0.30) per share, for a total transaction of £11,000 ($14,800.86). Corporate insiders own 5.24% of the company’s stock.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

? Point-of-Care analysers in the key areas of Hematology and Diabetes

? Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.